Abstract
“Janeiro Roxo” (Purple January) is a Brazilian campaign to raise awareness about leprosy and its early symptoms. The negative influence of the COVID-19 pandemic on institutional campaigns was especially relevant for the control of leprosy, if considered its status of neglected disease by the media. Google Trends (GT) is a free tool that tracks accesses to given terms on Google. Using GT we studied (i) impact of “Janeiro Roxo” on public interest on leprosy in the last 5 years; (ii) public interest during and after COVID-19 pandemic; (iii) patterns of public interest in self-identification of leprosy signs.
Methods GT tracking follows the popularity of topics in time range in “Relative Search Volume” (RSV) – proxies of public interest in a particular subject on a scale from 0 to 100. We selected “HANSENÍASE” (HAN) and “HANSENÍASE SINTOMAS” (leprosy symptoms) (H.SIN) to estimate public interest in leprosy and “self-diagnosis” during 261 weeks (August 2018 to 2023). Polynomial trend lines estimate trends over the period. Weekly RSV, monthly and annual means were compared using Analysis of Variance (ANOVA).
Results In 261 weeks: higher RSV to “HANSENÍASE” (HAN) compared to “HANSENÍASE SINTOMAS” (H.SIN); highest Monthly Means (MM) in January months (2019 to 2023) for both HAN and H.SIN.
Pandemic effect in “Janeiro Roxo”decrease in January MM 2021 compared to 2020 (24% to HAN, 25% to H.SIN). Both HAN/H.SIN reached pre-pandemic levels in January 2022/2023.
Breakpoints (points of abrupt change which influences trend lines) in the 26th week (February 2019); in the 55th and 213th week (September 2019 and 2022). Trend line (HAN): upward curve between 33rd-45th week (April to June 2019); pandemic downward trend between 120th-136th week (December 2020 to March 2021); upward trend curve between 220th-240th week (November 2022 to March 2023).
Conclusion “Janeiro Roxo” and in-person activities, among other media stimuli, have a relevant impact in terms of public interest in leprosy, even after their interruption due to pandemic. Considering their impacts on national searches, regional campaigns should be considered very successful. RSV to HAN may be due to “reactive searches” motivated by transient stimuli from campaigns, in an ephemeral and impersonal way. “Proactive searches” to H.SIN may be associated to those interested - in a personal way - in early symptoms and self-diagnosis. Internet-based campaign evaluation programs could be useful in integrating vulnerable regions and exposing their needs for assistance services.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The current research analyzed retrospectively open and anonymized data. According to Resolution 510/2016 of the Brazilian National Health Council, all research involving public domain data and unidentified participants does not require ethical assessment by the Research Ethics National Council system (CONEP). The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
